For all that wish to know further about the development of medication for prostate cancer, in April 2010, the FDA has approved treatment of advanced prostate cancer using the new vaccine, known as Provenge (Sipuleucel-T), which appear to spread beyond the prostate, associated with most less symptom with no response with standard hormone therapy. [...]
{ 0 comments }









